Singapore markets close in 3 hours 3 minutes
Straits Times Index
3,215.01 +1.36 (+0.04%) Nikkei
26,793.29 -208.23 (-0.77%) Hang Seng
20,127.81 -342.25 (-1.67%) FTSE 100
7,513.44 +123.46 (+1.67%) BTC-USD
29,345.58 -893.38 (-2.95%) CMC Crypto 200
656.65 -18.22 (-2.70%)
Merrimack Pharmaceuticals, Inc. (MACK)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
| Previous close | 5.25 |
| Open | 5.66 |
| Bid | 0.00 x 1000 |
| Ask | 0.00 x 2200 |
| Day's range | 5.28 - 5.66 |
| 52-week range | 3.66 - 7.41 |
| Volume | |
| Avg. volume | 17,580 |
| Market cap | 73.756M |
| Beta (5Y monthly) | 1.65 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.14 |
| Earnings date | 03 Aug 2022 - 08 Aug 2022 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | 13 Dec 2019 |
| 1y target est | 4.00 |
- Business Wire
Merrimack Reports First Quarter 2022 Financial Results
CAMBRIDGE, Mass., May 05, 2022--Merrimack Pharmaceuticals, Inc. (Nasdaq: MACK) [("Merrimack" or the "Company")] today announced its first quarter 2022 financial results for the period ended March 31, 2022.
- Business Wire
Merrimack Reports Full Year 2021 Financial Results
CAMBRIDGE, Mass., March 09, 2022--Merrimack Reports Full Year 2021 Financial Results
- Business Wire
Merrimack Reports Third Quarter 2021 Financial Results
CAMBRIDGE, Mass., November 04, 2021--Merrimack Pharmaceuticals Reports Third Quarter 2021 Financial Results
© 2022 Yahoo. All rights reserved.
